Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat.
Hyperlipidemia is associated with gram-negative sepsis. In this study we characterized the plasma lipoproteins of fasted and fed septic and control rats with respect to their lipid and apolipoprotein composition. Sepsis was induced by i.v. injection of 8 x 10(7) live Escherichia coli colonies/100 g body wt. Food was removed from fasted control and fasted E. coli-treated rats after injection. Fed rats were infused intragastrically with a nutritionally complete diet for 5 days prior to E. coli treatment. 24 h after treatment with E. coli, lipid and protein concentrations of very-low-density lipoprotein (VLDL) were over 2-fold higher in the fasted E. coli-treated rats than those of the fasted control rats. This appears to be due to a decrease in the clearance of VLDL. The relative composition of apolipoprotein B-48 and apolipoprotein E were lower while that of apolipoprotein B-100 was higher in fasted E. coli-treated rats than in fasted controls. Low-density lipoprotein (LDL) and high-density lipoprotein lipids were also significantly elevated, indicating greater synthesis of these particles during sepsis and food deprivation. By contrast, VLDL-triacyglycerol from fed, E. coli-treated did not differ from that of their respective controls although the total cholesterol remained elevated. Percentages of apolipoprotein B-48 and apolipoprotein B-100 increased while apolipoprotein E contributed significantly less to the total protein of VLDL from the E. coli-treated rats compared with controls. LDL lipids were also increased. In conclusion, gram-negative sepsis leads to marked changes in the plasma lipoprotein composition which may be attributed to altered hepatic synthesis, peripheral metabolism or hepatic uptake of lipoproteins and their remnants. These in turn may be a function of the nutritional status.
Lanza-Jacoby
S
S
Department of Surgery, Jefferson Medical College, Philadelphia, PA 19107.
Wong
S H
SH
Tabares
A
A
Baer
D
D
Schneider
T
T
D000818:Animals; D004926:Escherichia coli / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000097:blood* / Q000150:complications; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D018805:Sepsis / Q000097:blood* / Q000150:complications / Q000382:microbiology; D013217:Starvation; D014280:Triglycerides / Q000097:blood
D008074:Lipoproteins; D014280:Triglycerides